Repriming DNA synthesis: an intrinsic restart pathway that maintains efficient genome replication by Bainbridge, Lewis J et al.
Repriming DNA synthesis: an intrinsic restart pathway that 
maintains efficient genome replication
Article  (Published Version)
http://sro.sussex.ac.uk
Bainbridge, Lewis J, Teague, Rebecca and Doherty, Aidan J (2021) Repriming DNA synthesis: 
an intrinsic restart pathway that maintains efficient genome replication. Nucleic Acids Research, 
49 (9). pp. 4831-4847. ISSN 0305-1048 
This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/101284/
This document is made available in accordance with publisher policies and may differ from the 
published  version or from the version of record. If you wish to cite this item you are advised to 
consult the publisher’s version. Please see the URL above for details on accessing the published 
version. 
Copyright and reuse: 
Sussex Research Online is a digital repository of the research output of the University.
Copyright and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable, the material 
made available in SRO has been checked for eligibility before being made available. 
Copies of full text items generally can be reproduced, displayed or performed and given to third 
parties in any format or medium for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge, provided that the authors, title and full bibliographic 
details are credited, a hyperlink and/or URL is given for the original metadata page and the 
content is not changed in any way. 
Published online 21 March 2021 Nucleic Acids Research, 2021, Vol. 49, No. 9 4831–4847
doi: 10.1093/nar/gkab176
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ABSTRACT
To bypass a diverse range of fork stalling impedi-
ments encountered during genome replication, cells
possess a variety of DNA damage tolerance (DDT)
mechanisms including translesion synthesis, tem-
plate switching, and fork reversal. These pathways
function to bypass obstacles and allow efficient
DNA synthesis to be maintained. In addition, lag-
ging strand obstacles can also be circumvented by
downstream priming during Okazaki fragment gen-
eration, leaving gaps to be filled post-replication.
Whether repriming occurs on the leading strand has
been intensely debated over the past half-century.
Early studies indicated that both DNA strands were
synthesised discontinuously. Although later studies
suggested that leading strand synthesis was contin-
uous, leading to the preferred semi-discontinuous
replication model. However, more recently it has
been established that replicative primases can per-
form leading strand repriming in prokaryotes. An
analogous fork restart mechanism has also been
identified in most eukaryotes, which possess a spe-
cialist primase called PrimPol that conducts reprim-
ing downstream of stalling lesions and structures.
PrimPol also plays a more general role in maintaining
efficient fork progression. Here, we review and dis-
cuss the historical evidence and recent discoveries
that substantiate repriming as an intrinsic replication
restart pathway for maintaining efficient genome du-
plication across all domains of life.
INTRODUCTION: THE EUKARYOTIC DNA REPLICA-
TION MACHINERY
During the synthesis phase (S phase) of the cell cycle,
genome replication is performed by the replisome. This
multi-protein complex consists of the major replicative en-
zymes required to accurately duplicate DNA. Replisome
proteins include the DNA polymerases ,  and ε, the
Cdc45–MCM–GINS (CMG) DNA helicase complex, as
well as additional proteins such as AND-1 (yeast Ctf4),
Timeless (Tof1), Claspin (Mrc1), Tipin (Csm3), Topoiso-
merase I, Mcm10, Replication Protein A (RPA) and FACT
(1). Replisome assembly begins in G1 phase with the bind-
ing of the minichromosome maintenance (MCM) complex
to defined loci known as origins of replication (2). Load-
ing of the MCMs to origins is dependent on prior binding
of the Origin Recognition Complex (ORC), comprised of
ORC1–6, and the proteins Cdc6 and Cdt1 (3). The MCM
replicative helicase is loaded as an inactive, double hexamer
structure (4), and is activated when DNA replication be-
gins at the start of S phase (reviewed in (5)). The activa-
tion process remodels the MCM complex into two active
CMG complexes, one for each direction of synthesis. Encir-
cling each leading DNA strand, the active complex moves
away from the centre of the origin and allows for the assem-
bly of the remaining replisome components on the resulting
single-stranded DNA (ssDNA) (6).
While the bulk of synthesis is completed by the major
replicative polymerases (Pol  and Pol ε), these enzymes lack
the ability to initiate DNA synthesis de novo. Therefore, a
short ribonucleotide primer is required, from which 3′ ex-
tension can be continued by the replicative polymerases (7).
In the conventional model, the initiating primers on both
the leading and lagging strand are generated by the Pol -
primase complex. This primase synthesises a short RNA
primer de novo, from which Pol  can extend using dNTPs
to create an RNA-DNA primer. This is then further ex-
tended by a primary replicative polymerase with proofread-
ing capacity, to ensure high fidelity synthesis. Polymerase
*To whom correspondence should be addressed. Tel: +44 1273877500; Fax: +44 1273678121; Email: a.j.doherty@sussex.ac.uk
†The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.
C© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
4832 Nucleic Acids Research, 2021, Vol. 49, No. 9
usage throughout replication is well-coordinated, with the
majority of leading strand synthesis undertaken by Pol ε,
while Pol  copies the lagging strand (8). However, this
may not always be the case, as Pol  can conduct synthe-
sis on both strands in yeast, both during bulk replication
and following replication restart (9,10). All polymerases ex-
clusively synthesise DNA in a 5′ to 3′ direction. For this rea-
son, the lagging strand is synthesised in short, discontinu-
ous fragments, as the DNA is unwound to allow coupled
unidirectional replication to occur (11,12). The Pri1/Pri2
(PriS/L) primase complex frequently synthesises ribonu-
cleotide primers on the lagging strand template, from which
Pol  and Pol  can extend (13). The generally accepted
model for leading strand synthesis involves continuous syn-
thesis by Pol ε from the Pri1/Pri2 generated primer at the
origin until termination (14). Pol ε is more processive than
Pol , in keeping with its role of replicating the majority
of the leading strand (15,16). Termination of DNA repli-
cation occurs either when converging replication forks meet
or when the end of the chromosome is reached (17). The
replication machinery is then unloaded by the ATPase p97
(cdc48 in yeast), to prevent re-replication of DNA (18).
Unlike replication initiation, which is well studied in eu-
karyotes, replication termination has received significantly
less attention. For this reason, the current understanding of
replication termination is somewhat incomplete.
Replication stress: derailing the DNA replication machinery
During genome duplication, the replication fork encoun-
ters a myriad of conditions and obstacles that can affect the
progression of DNA polymerases, resulting in replication
stress. Pol  and Pol ε operate with high fidelity to accu-
rately copy DNA and stall at atypical bases or DNA struc-
tures, due to an inability to bypass distorted templates (19).
Causes of polymerase stalling include unrepaired DNA le-
sions generated by both endogenous and exogenous sources
(20), DNA secondary structures such as G4 quadruplexes
(21) or R loops (22), proteins tightly bound to DNA (23),
repetitive sequences, including common fragile sites (24),
and increased expression of oncogenes (25,26). Replication
stress occurs when the replisome encounters such features
on the DNA template, causing slowing or stalling of the
fork, which, in turn, can lead to slower or reduced synthesis,
fork collapse, DNA breaks, and checkpoint activation (27).
The intra-S checkpoint allows for fork stabilisation and the
prevention of origin firing, as well as the further slowing
of DNA replication. Mutations in the checkpoint response
proteins reveal the severe effects of prolonged replication
stress. For example, mutations in the Ataxia Telangiectasia
and Rad3-related (ATR) gene can cause Seckel syndrome
(microcephalic primordial dwarfism), characterised by mi-
crocephaly and intellectual disability (28).
To avoid replication fork collapse or mutagenesis, and
ultimately maintain genome stability, stalling impediments
must either be resolved or bypassed efficiently. DNA re-
pair mechanisms, such as nucleotide excision repair (NER),
can be employed outside of S phase to remove damaged
DNA nucleotides before the onset of replication. NER is
a multistep process that involves several proteins (reviewed
in (29)) and is particularly important for the removal of
bulky lesions, like those introduced by ultra-violet (UV)
light. Importantly, NER is a relatively slow process that is
not infallible, and, additionally, lesions can arise during S
phase. Therefore, unrepaired lesions are frequently present
in DNA during replication, where they have the potential
to affect polymerase progression.
The consequences of stalling events vary, depending upon
which strand the arresting structure or lesion resides on. It is
generally accepted that the constant cycles of priming dur-
ing discontinuous synthesis reduces the impact of lagging
strand lesions on fork progression, as a downstream primer
can readily be synthesised as part of this canonical repli-
cation process. Providing the replicative helicase is not im-
paired by a lagging strand barrier, the lagging strand poly-
merase (Pol ) can dissociate and restart replication from a
new primer, bypassing the impediment (30). In fact, overall
fork progression is hardly affected by lagging strand dam-
age in reconstituted replisome collisions (31). The repair of
stalling lesions can subsequently be conducted in a post-
replicative manner. In contrast, large stretches of ssDNA
are generated by leading strand polymerase stalling, caused
by the continued unwinding of the DNA template by the
replicative helicase; this is known as helicase-polymerase
uncoupling (32). ssDNA is fragile and prone to breakage
and is therefore protected by the binding of RPA. RPA
binding acts as a marker of replication stress and can trig-
ger the S phase checkpoint response by activating the ATR-
mediated DNA damage response cascade. This prevents cell
cycle progression when replication is incomplete (33). A
wide variety of DNA damaging agents, including UV dam-
age, crosslinking agents, polymerase inhibitors or stalling-
induced replication stress, can localise and activate ATR by
generating stretches of ssDNA. This is bound by RPA, and
the 5′ primer end can be bound by the Rad9-Rad1-Hus1
(9-1-1) complex (34). This pathway, therefore, orchestrates
multiple branches of the cell’s replication stress response.
The activity of ATR in the stress response pathway is re-
viewed in (35). ATR also decreases origin firing elsewhere
in the genome, which prevents excessive ssDNA formation
that would exhaust cellular RPA resources (36).
Damage tolerance pathways: mechanisms to maintain active
replication
DNA damage tolerance (DDT) mechanisms are employed
during S phase to bypass DNA lesions, structures and other
obstacles without removing them and these impediments
will be resolved by a variety of post-replicative pathways.
This prevents fork stalling and allows DNA replication to
continue in a timely manner, preventing replication stress.
There are several mechanisms that cells rely on to continue
replication past damage, including, translesion synthesis,
template switching, fork reversal and firing of dormant ori-
gins (Figure 1).
Virtually all polymerases can perform synthesis across
damaged DNA to some degree, but polymerases with high
fidelity are the least adept at this process and are there-
fore prone to stalling. To tolerate damage, atypical bases
can be bypassed by specialised polymerases during transle-
sion synthesis (TLS) (37). These specialised Y family TLS
polymerases (Pol k, Pol , Pol , Rev1, and Pol  ) can re-
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Figure 1. DNA damage tolerance pathways. Obstacles on the DNA template (red diamond) block ongoing DNA replication (blue arrows) and lead to
fork stalling. This leads to helicase/polymerase uncoupling, generating tracts of ssDNA, which is bound by RPA (yellow circles). DNA damage tolerance
mechanisms allow DNA replication to continue in the presence of such impediments. Translesion synthesis employs specialised polymerases (green oval)
to insert bases opposite damaged templating bases (orange line indicates this insertion). Fork reversal begins as the recombinase Rad51 (orange circle)
replaces RPA, and, along with the recruitment of additional factors, promotes the transient remodelling of a replication fork into a stabilised ‘chicken
foot’ structure to allow for lesion repair or template switching. Rad51 and BRCA 1/2 (grey oval) are factors that prevent degradation of this reversed fork
structure. Template switching requires strand invasion to use the newly replicated strand as a template instead of the damaged parental strand. Dormant
origin firing is activated when the replication fork slows or stalls to ensure replication is completed in a timely manner. Dormant origin firing can occur
alongside the other mechanisms of DDT. Finally, repriming requires de novo primer synthesis downstream of the lesion (red arrow) from which replication
can be resumed by a replicative polymerase. In vertebrate cells, this is dependent on PrimPol (pink oval), which is recruited by RPA to ssDNA.
place the replicative polymerase in an attempt to continue
replication. TLS polymerases are able to accommodate dis-
torted bases because they are endowed with more open ac-
tive sites than the replicative polymerases. Because of this,
TLS polymerases display low processivity, fidelity and effi-
ciency, as their larger active sites interact less securely with
DNA templates (38). Despite their inherent low fidelity,
each specialised TLS polymerase is able to bypass at least
one specific kind of DNA damage with relatively high fi-
delity: for example, Pol  accurately replicates over UV-
induced cyclobutene pyrimidine dimers (CPD) lesions but
is very inefficient at bypassing 6–4 photoproducts in vitro
(39). Rev1 can bypass abasic sites by incorporating deoxy-
cytidine bases (40). TLS polymerases lack the 3′-5′ exonu-
clease activity found in Pol  and Pol ε, and this absence
of ‘proofreading’ allows these polymerases to avoid enzy-
matic idling, where the proofreading exonuclease would re-
move any incorrect bases incorporated by the polymerase
(41). The regulation of TLS polymerase activity is tightly
controlled, in part by the activity of Proliferating Cell Nu-
clear Antigen (PCNA), a DNA clamp that forms part of the
replisome. Monoubiquitination of PCNA by Rad6/Rad18
is a signal for the recruitment of TLS polymerases. How-
ever, polyubiquitination of PCNA––remarkably at the same
amino acid, K164 (42)––will signal for the assembly of a dif-
ferent DDT pathway: template switching.
Template switching is a recombination-mediated mech-
anism of fork restart and is therefore significantly more
accurate than using TLS polymerases, as the correct se-
quence can be copied from an undamaged template (43).
The process of template switching involves the initial steps
of TLS, including recruitment of Rad18 by RPA and chro-
matin remodelling by INO80. However, at the point of
PCNA ubiquitination by Rad6/Rad18, Rad18 may recruit
MMS2-UBC13 and HTLF/SHPRH, which polyubiquiti-
nates K164 to stimulate template switching (44–47). The 9–
1–1 clamp is then loaded to the 5′ end of the ssDNA, leading
to Exo1 recruitment (48), and Rad51/BRCA2/Dss1 medi-
ated strand invasion of the sister chromatid (49). This fa-
cilitates the synthesis of the unreplicated sequence opposite
the damaged template by Pol . After replication has been
completed, the newly synthesised strand switches back to its
original position, leaving no unreplicated DNA but instead
a sister chromatid junction (SJC) that requires resolution
by BLM (Sgs1)/TOP3 (Top3)/RMI1/2 (RMI1) (50). This
process is complex and requires the timely recruitment of a
significant number of proteins, the formation and resolution
of a D-loop and the resolution of an SJC before replication
can continue. Unlike TLS, this process is considered to be
error-free.
Fork reversal is another mechanism by which replication
of a damaged template can be avoided, by using the newly
synthesised nascent strand as a template. Fork reversal leads
to the formation of a regressed fork, which is commonly
referred to as a ‘chicken foot’ structure (51,52). This pro-
vides the cell with the opportunity to remove the DNA le-
sion after fork regression but before replication restart, or,
alternatively, to bypass it through template switching once
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the fork restarts. Reversed forks can also converge with on-
coming replication forks, bypassing the need for fork restart
(53). Several factors have been implicated in protecting the
reversed fork, including both BRCA1 and BRCA2, and
the binding of Rad51 to RPA covered ssDNA. Fork rever-
sal is dependent on the action of SMARCAL1, HLTF or
ZRANB3 (54). The majority of fork reversal mechanisms
have only recently been reported (reviewed in (55)) and fur-
ther studies are required to fully elucidate the molecular
mechanisms underpinning this process.
An additional method employed by cells to tolerate repli-
cation stress is dormant origin firing, a mechanism by which
the inactive origins distributed throughout the genome are
activated. In G1, when the MCM complex is loaded onto
origins, significantly more origins are loaded with inactive
complexes than are initially activated. The remaining inacti-
vated origins can then be activated in response to replication
stress, despite the activation of the ATR-dependent S phase
checkpoint, which decreases late-stage origin firing (56). In
fact, Chk1, required for the suppression of origin firing, is
paradoxically required for the dormant origin activation by
distinguishing between origins within currently active repli-
cation factories and those outside (57).
While all of these DDT pathways are now well estab-
lished, the existence of another conserved mechanism for
the bypass of replication fork barriers has been debated by
the field for over half a century. The canonical model for
discontinuous lagging strand synthesis has long been ac-
cepted and, in keeping with this, lesion bypass can be ex-
plained simply by constant cycles of priming. However, the
existence of a bespoke pathway to reprime stalled leading
strand synthesis has been the subject of much debate. Here,
we review the available evidence for repriming as a canoni-
cal mechanism that promotes DNA damage tolerance and
replication restart during leading strand duplication.
Early investigations to elucidate a model of DNA replication
In the years following the discovery of the structure of
double-stranded DNA (dsDNA) by Watson and Crick, the
field moved quickly to develop a model that described the
mechanism of its duplication (58). The isolation of the first
DNA polymerase (Escherichia coli DNA polymerase I) in
the late 1950s provided the first example of an enzyme with
the ability to catalyze the synthesis of new DNA strands
(59). Interestingly, this polymerase synthesised DNA in a
specific 5′ to 3′ direction, which has since been shown to be
an inherent feature of all known polymerase enzymes (60).
This directionality of synthesis posed an interesting ques-
tion regarding the nature of replication of each of the anti-
parallel strands in dsDNA. While one strand could, theoret-
ically, be replicated continuously as the DNA is unwound,
the other strand must somehow be replicated backwards (3′
to 5′) to allow for coupled, unidirectional fork progression.
In a classic study investigating replication intermedi-
ates in E. coli, Okazaki et al. used alkaline sucrose gra-
dient sedimentation approaches to uncover low molecu-
lar weight (LMW) DNA fragments (Okazaki fragments),
synthesised during a quick pulse of radioactive labelling
(61,62). The failure to detect any high molecular weight
(HMW) molecules after short pulse times led to the pos-
tulation that all DNA is synthesised in small pieces. By
adding a chase of unlabelled nucleotides into the protocol,
the conversion of the radioactive LMW intermediates into
fragments of HMW could be observed, hinting at the ex-
istence of a joining process and confirming that the small
fragments observed were, in fact, intermediates of chro-
mosomal DNA synthesis (61). Subsequent studies found
that the newly synthesised DNA fragments were assem-
bled into larger molecules by the further joining of addi-
tional fragments to the 3′ end of pre-existing material, as
would be expected (63,64). The DNA ligase enzyme was
later implicated in the joining of the small fragments, and,
accordingly, almost all DNA is present in small molecules
in cells expressing temperature-sensitive ligase mutants at
non-permissive temperatures (65,66). DNA ligase was also
shown to join these fragments in both Saccharomyces cere-
visiae and Schizosaccharomyces pombe (67,68), and human
DNA ligase I is now well characterised in this role (reviewed
in (69)). E. coli harbouring mutations in DNA polymerase
I (PolA) also displayed an impairment in the joining of
LMW fragments into HMW molecules (70). This suggested
a model where PolA fills in gaps between fragments before
DNA ligase catalyses the formation of a phosphodiester
bond to seal the individual pieces together.
Okazaki’s findings offered a solution to the directional-
ity problem, whereby the strand requiring synthesis in the
3′ to 5′ direction (now known as the lagging strand) could
be synthesised in short, discontinuous fragments, which can
subsequently be ligated into a completed product. Support-
ing this, the small fragments isolated by Okazaki et al. were
shown to contain short stretches of RNA, which provided
insights into the mechanism by which they are produced
(71). Since DNA polymerases are incapable of de novo syn-
thesis, short RNA primers would be required at frequent
intervals on the exposed lagging strand to act as substrates
for the initiation of DNA synthesis by the replicative poly-
merase. The presence of these RNA species signified that
the short fragments are the result of true initiation events
and established a model for lagging strand synthesis that
allows replication to progress in the same direction as its
anti-parallel partner strand, which is also replicated in a 5′
to 3′ direction (71).
Following these seminal studies, there was considerable
debate regarding the nature of leading strand (5′ to 3′) syn-
thesis; was it synthesised continuously from the origin to
termination (semi-discontinuous model) or did synthesis
frequently start and stop in a similar manner to the lagging
strand (discontinuous model) (Figure 2A)? Logically, repli-
cation restart on the leading strand seems unnecessary, as
continuous 5′ to 3′ synthesis from the origin until termina-
tion is mechanistically possible. In theory, the 3′-OH of the
nascent leading strand can prime further replication and,
in addition, discontinuous synthesis would be more energy-
and time-consuming. However, all replication intermediates
detected in Okazaki’s studies were LMW fragments, sup-
porting a discontinuous model where synthesis is reinitiated
frequently on both strands. The evidence put forward to set-
tle this debate over the coming decades was conflicting.
Despite the early evidence pointing towards a fully dis-
continuous model of replication, later studies introduced
contradictory evidence that supported the simpler semi-
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Figure 2. Uncovering models of DNA replication. (A) In the semi-
discontinuous model of DNA replication, leading strand synthesis is con-
tinuous from origin to termination and the lagging strand is synthesised in
short fragments. Theoretically, if ligation is prevented, two size classes of
replication intermediates would be produced: a HMW continuous leading
strand and LMW fragments from the lagging strand. In the discontinuous
model, both strands of DNA are synthesised as fragments and all DNA
initially consists of LMW fragments. (B) The protocol used in the sem-
inal studies of Rupp and Howard–Flanders to investigate DNA replica-
tion intermediates in bacteria following UV damage. Escherichia coli cells
were grown in unlabelled medium (black arrow) before being irradiated
with UV-C and transferred to media containing radioactive thymidine (or-
ange arrow). After 40 min of labeling, the cells were collected for analysis.
DNA was harvested from either control or irradiated cultures and subject
to alkaline sucrose gradient centrifugation. The sedimentation showed that
DNA fragments extracted from irradiated cells were significantly smaller
than those from control cells. (C) The results were interpreted to indicate
that gaps were present in the nascent DNA opposite the CPDs (red) in-
duced by UV irradiation.
discontinuous model which, perhaps due to its practical
appeal, was well received by the field. The results of stud-
ies utilising an in vitro E. coli DNA synthesis system pro-
vided compelling evidence in support of continuous leading
strand synthesis (72). Fragments of DNA produced in this
system during ligase inhibition were reproducibly shown
to fit into one of two distinct size classes; Okazaki frag-
ments that were produced with a low sedimentation coef-
ficient and a distinct class of larger labelled molecules. In-
terestingly, the distribution of DNA between the two classes
was roughly equal and further investigation confirmed that
fragments in one class were complementary to fragments in
the other, a sign that they originated from opposing (lead-
ing or lagging) strands (73). These data were indicative of
one strand being synthesised continuously while the other
one was produced discontinuously, adding support to the
semi-discontinuous model. In addition, multiple studies ex-
ploiting rolling circle-type DNA replication systems were
able to produce long leading strand products of 40–500 kb
in length, with no evidence of dissociation (74,75). Thus, the
semi-discontinuous model of replication was well supported
by in vitro studies (72–75).
The evidence regarding the nature of bacterial leading
strand synthesis was often contradictory between the pub-
lished in vitro and in vivo studies, with the latter usually
supporting a fully discontinuous model. However, evidence
supporting the use of a continuous mechanism of leading
strand synthesis in vivo is provided in some early literature.
Iyer and Lark investigated the mechanism of production of
intermediate molecular weight and HMW replication inter-
mediates that were generated during pulse labelling experi-
ments (63). Their results showed nucleotides being added to
the 3′ end of nascent DNA strands, suggesting continuous
synthesis. Direct in vivo evidence for a semi-discontinuous
model was later reported, however, this was dependent on
the presence of PolA, which is now known to fill in gaps
generated by discontinuous synthesis, as described earlier
(76). The method of reaction termination (pyridine-KCN)
used in the two studies presented above has since been called
into question (77). The use of a pyridine-KCN termination
pulse permits the ligation of nascent DNA fragments after
application, and this is likely the source of the long ‘contin-
uous’ fragments. By using a more rapid and robust method
of termination, it was shown that all nascent DNA frag-
ments were short in vivo, agreeing with previous studies and
supporting a discontinuous model of replication (77).
Subsequent studies set out to explain the disparities be-
tween the in vitro results and those observed in biologi-
cal systems. One possibility that had not been excluded by
early studies was that the fragments observed in vivo could
be a result of DNA processing or excision repair activities.
Uracil is a common lesion present in DNA, resulting from
either deamination of cytosine or misincorporation of de-
oxyuridine 5′-triphosphate nucleotide (dUTP). In order to
maintain genomic integrity, uracil must be detected and re-
moved by base excision repair (BER), a process that gen-
erates breaks, or gaps, in the backbone of the DNA chain.
Examining DNA synthesis in E. coli lysates had previously
uncovered two size classes of intermediates (72). Increasing
the concentration of dUTP present in the lysate solution led
to a decrease in the sedimentation coefficient of the larger
4836 Nucleic Acids Research, 2021, Vol. 49, No. 9
size class, representing the generation of smaller fragments
(78). The addition of dUTP to in vitro reactions produced
smaller DNA fragments with a sedimentation profile that
was similar to DNA obtained from in vivo experiments. The
conclusion was, therefore, that the small DNA fragments
observed in previous experiments could be explained simply
by dUTP incorporation and excision and it was deemed no
longer necessary to consider possible leading strand reiniti-
ation events. However, this conclusion was strongly refuted
by other evidence published at the same time (79). Compar-
ing the sedimentation profiles of DNA produced by ligase-
deficient E. coli to DNA from a strain that was also deficient
in excision-repair of uracil demonstrated little or no differ-
ence in the sizes of fragments produced by either strain in
vivo. Subsequent studies also concluded that neither DNA
processing nor uracil excision were found to affect the size
of replication intermediates (80). While this added support
to the idea of multiple initiation events on both strands, it
was not direct evidence and the semi-discontinuous model
was generally still considered to be the most convincing.
A recent study has revisited the questions surrounding
the origin of replication intermediates in bacteria (81). Sur-
prisingly, nearly all of the LMW leading strand products
observed in earlier studies can be explained by fragmenta-
tion as part of excision-repair processes. Mutants deficient
in BER, mismatch repair (MMR), NER and ribonucleotide
excision repair (RER) were able to perform largely contin-
uous synthesis on the leading strand, suggesting that these
could be responsible for fragmenting DNA. In particular,
the RER pathway is responsible for most fragmentation
events, which could explain why earlier studies investigating
dUTP excision failed to detect a noticeable effect (79,80).
The implication of this work is, therefore, that all DNA is
initially synthesised with a number of incorrect bases and
requires extensive excision repair in order to become mature
DNA. Such events generate discontinuities in the nascent
chain that produce the DNA fragments detected in previous
studies. Interestingly, their data did not show chromosome-
length continuous fragments in the absence of any excision
pathways, in fact, DNA fragmented in two size classes, with
the largest class of fragments determined to be 50–70 kb.
This supports Okazaki’s original model for the discontinu-
ous synthesis of both strands of DNA, albeit with two size
classes of fragments, presumably originating independently
from each of the DNA strands.
Studying replication after damage: new insights into the repli-
cation model
Although the studies described above helped to delineate a
working model for the canonical mechanism of DNA repli-
cation in unperturbed conditions with normal amounts of
fork stalling caused by endogenous sources, examining how
DNA is copied following the application of fork stalling
agents also provided critical insights into how this duplica-
tion process operates. In the late 1960s, Rupp and Howard-
Flanders conducted a seminal study, which explored the fate
of DNA when cells were permitted to replicate following
UV damage (82). By utilising NER-deficient E. coli strains,
UV-induced pyrimidine dimers could persist into S phase.
At the time, it was unknown whether replication would be
stalled by these photo-lesions or continue past this damage
with minimal perturbation. By measuring tritiated thymi-
dine incorporation following UV irradiation, they deter-
mined that each lesion caused ∼10-s delay to the replication
fork, however, the lesions did not completely block repli-
cation. This observation prompted the central question of
the study: was the bypass of UV lesions continuous or dis-
continuous in nature? To address this question, they utilised
rapid pulses of radioactive labelling to mark newly synthe-
sised DNA in damaged and undamaged cells that could
be subjected to alkaline sucrose gradient centrifugation for
comparison (Figure 2B). DNA originating from cultures
that weren’t exposed to UV sedimented in large pieces, how-
ever, strikingly, DNA synthesised following UV exposure
sedimented in significantly smaller pieces; a sign of discon-
tinuities in the nascent chains. The results were interpreted
to indicate the presence of single-stranded gaps in the DNA
of daughter strands following UV exposure. Interestingly,
the gaps observed were spaced at distances roughly corre-
lating to the predicted distance between CPDs produced
at the specific UV dose used, suggesting the gaps may re-
side opposite damaged bases (Figure 2C). Further work
demonstrated that these ssDNA gaps were ∼1000–2000 bp
in length (83). Over time, the ssDNA gaps opposite CPDs
were repaired by sister-chromatid exchange (SCE) to pro-
duce detectable full-length chromosomal DNA (84). The
discovery of gaps in all nascent DNA following damage led
to the postulation that replication restart downstream of
polymerase-stalling damage could occur on both strands of
DNA.
Repeating the initial experiments conducted by Rupp and
Howard-Flanders in mammalian (Chinese hamster) cells
produced ssDNA gaps similar to those observed in E. coli,
which were also filled in over time (85). Gaps were later dis-
covered in DNA from human cells following UV irradiation
(86). In contrast to the results in E. coli, no evidence of gap-
filling by an SCE mechanism could be found in mammalian
cells; however, there was evidence of gap filling by DNA
synthesis that was not coupled to SCE (87). The evidence
for discontinuous synthesis after damage provided by these
early studies suggested an inherent ability of the replisome
to skip synthesis opposite a lesion or replicative impedi-
ment and restart replication downstream on both the lead-
ing and lagging strand. One model proposed to explain the
observed results involved the generation of a de novo primer
downstream of a stalling lesion, from which the replicative
polymerase can resume synthesis, as occurs on the lagging
strand.
Following the publication of these studies, there was lit-
tle further work into resolving the questions surrounding
discontinuous leading strand synthesis. Replication restart
downstream of lesions was still considered unlikely and the
leading strand was generally considered by the field to be
synthesised continuously (88). The discovery of TLS poly-
merases in the late 1990s provided a compelling solution for
lesion bypass that didn’t require reinitiating synthesis on the
leading strand (89–91). The ability of these enzymes to syn-
thesise past damaged bases allowed the development of new
models, which almost all involved polymerase switching to a
TLS enzyme at the active fork, maintaining continuous syn-
thesis of the nascent chain. The solutions offered by models
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involving the newly discovered TLS pathways were prefer-
able to models which went against the dogma of continuous
leading strand synthesis.
In the early 2000s, the debate over continuous versus dis-
continuous leading strand synthesis was still ongoing (92),
then, in 2006, two significant studies provided compelling
evidence supporting a model where leading strand synthe-
sis can be initiated downstream of a lesion, prompting a re-
evaluation of the semi-discontinuous model. The first study
combined 2D gel electrophoresis with electron microscopy
to inspect DNA derived from UV-irradiated NER-deficient
S. cerevisiae cells (93). Single-stranded DNA gaps in both
strands were directly visualised behind the replication fork.
In WT cells, the gaps were filled in over time. However, in
cells deficient in TLS or homologous recombination, gaps
persisted after completion of S phase suggesting they are
repaired by a post-replicative repair mechanism(s). The sec-
ond study provided the first mechanistic evidence support-
ing the existence of a repriming mechanism in E. coli, as
Rupp and Howard-Flanders had originally proposed (94).
By using a terminal 3′ dideoxynucleotide on the simulated
nascent leading strand of a forked template, Heller & Mari-
ans showed that synthesis could resume downstream of the
blocked end, without repair of the lesion; a process that
would require de novo synthesis (94). This discontinuous
synthesis was dependent on both the replicative primase
(DnaG) and helicase (DnaB), suggesting that primer syn-
thesis can take place on the leading strand to allow replica-
tion to resume after fork stalling events.
Roles of replicative primase enzymes in leading strand repli-
cation
As discussed above, both leading and lagging strand prim-
ing is performed by the replicative primase DnaG in E.
coli (94,95). The roles of DnaG and DnaB (helicase) in
repriming replication restart have now been also established
(96,97). It is, however, important to note that although bac-
terial replisomes bear many mechanistic similarities to that
of eukaryotes, both systems have seemingly evolved inde-
pendently (reviewed in (98)). One key difference in their
mechanisms is the direction of travel of their respective
replicative helicases. In E. coli, DnaB traverses along the
lagging strand in a 5′ to 3′ direction, while the eukaryotic
MCM helicase moves 3′ to 5′, placing it on the leading
strand (99,100). Furthermore, as discussed previously, the
eukaryotic system divides the labour of bulk synthesis be-
tween Pol ε and Pol , whereas the majority of E. coli repli-
cation is conducted by multiple copies of the C-family poly-
merase, DNA Polymerase III (101). Interestingly, the pri-
mase enzymes of each domain of life are also distinct, de-
spite their functional similarities. Bacterial DnaG primases
are more closely related to topoisomerases, both having a
common TOPRIM fold (102). In contrast, the so-called eu-
karyotic primases (Pri1/PriS) evolved from a primordial
RNA recognition motif (RRM) with a diverse range of dis-
tantly related homologues found in all domains of life, albeit
their specific roles in priming genome replication appears to
be restricted to viruses, archaea and eukarya (103).
During eukaryotic replication, RNA-DNA primers are
generated by the Pol -primase complex, consisting of four
distinct subunits: p180, p74, p58 and p48 (104). The primase
is formed of the latter two subunits, with p48 (Pri1/PriS)
acting as the catalytic subunit and p58 (Pri2/PriL) acting to
stabilise the primase (105). A temperature-sensitive mutant
of the budding yeast Pri1 subunit has allowed investigation
of the role of the primase in vivo (106). DNA synthesis in
the mutant is partially defective at the permissive tempera-
ture, however, at the restrictive temperature, DNA synthesis
fails at an early step following release from G1 arrest. These
results indicated that the primase is required to maintain
ongoing DNA synthesis. Interestingly, cells expressing the
mutant primase fail to slow the rate of S phase progression
following methyl methanesulfonate (MMS)-induced DNA
damage. Investigating this effect further revealed evidence
suggesting a role for Pri1 in the Rad53p-dependent check-
point pathways that regulate cell cycle progression in re-
sponse to DNA damage. Pri1 mutants have recently been
shown to experience an increase in premature sister chro-
matid separation (107).
Reconstituting the yeast replisome in vitro has facilitated
further studies into the roles of Pol -primase and pro-
vided insights into priming events on the leading strand. In
one study, the Pol -primase complex was shown to syn-
thesise a primer on the leading strand of a forked sub-
strate and then extend this using its polymerase activity,
or hand over to Pol ε or Pol  (108). Additionally, when
a primer was provided, the enzyme complex preferentially
extended this, rather than synthesise a de novo primer. The
study found no evidence of repriming on the leading strand.
In another recent study, lagging strand priming by Pol -
primase complex to bypass a CPD was found to be fast and
efficient, while leading strand repriming was inefficient for
re-establishing replication beyond the lesion (31). Interest-
ingly, the efficiency of leading strand repriming was related
to the availability of RPA, where depleting the pools of RPA
increased priming efficiency. Pol -primase has long been
thought to prime the leading strand at the origins. However,
a recent examination of the establishment of bi-directional
leading strand synthesis in a reconstituted yeast system de-
termined that leading strand synthesis is, in fact, initiated
from a lagging strand primer on the opposite side of the ori-
gin (109). Overall, this evidence suggests that budding yeast
Pol -primase does not play a major role in priming lead-
ing strand synthesis, at least at origins, nor does it appear to
efficiently reprime on this strand to promote damage toler-
ance.
While the availability of temperature-sensitive mutants
and in vitro reconstituted replisome systems have allowed
the study of some of the functions of the budding yeast pri-
mase, the mammalian enzyme has proven more difficult to
study. In a similar manner to the yeast homologue, human
Pol -primase forms the replicative primase complex that
is composed of the DNA polymerase  subunits (POLA1
and POLA2) and the DNA primase subunits PRIM1 and
PRIM2 (110). There is currently no substantial evidence to
suggest that the human Pol -primase complex plays a role
in DNA damage tolerance on the leading strand. There-
fore, in contrast to prokaryotic cells, it is unlikely that stalled
leading strand synthesis in eukaryotic cells can be restarted
from downstream primers synthesised by the replicative pri-
mase.
4838 Nucleic Acids Research, 2021, Vol. 49, No. 9
The observations described above raise important ques-
tions regarding the strand-specific differences in priming ef-
ficiency displayed by Pol -primase. What enables the en-
zyme to regularly prime the lagging strand efficiently, while
priming on the leading strand is so inefficient? Most ss-
DNA is rapidly coated in RPA, which has been shown to
inhibit Pol -primase activity, however, despite this, the lag-
ging strand is primed efficiently by this complex (31). Dur-
ing replisome progression, the CMG encircles and translo-
cates along the leading strand, while the lagging strand is
excluded (6). Pol -primase is kept in close proximity to
CMG via an interaction with Ctf4 (AND-1 in humans),
and it is possible to consider that this proximity may pre-
vent RPA from binding the lagging strand before it reaches
the primase, allowing efficient priming to take place dur-
ing Okazaki fragment generation (111). Outside of this spe-
cific scenario, for example during helicase uncoupling af-
ter leading strand stalling events, ssDNA is rapidly coated
in RPA, which would prevent Pol -primase from priming
or repriming (31). Another possibility is that Pol -primase
could be regulated by auxiliary factors that limit its us-
age. For example, while the absence of Ctf4 in reconstituted
yeast systems does not seem to affect lagging strand syn-
thesis on chromatin in vitro, Ctf4 has been suggested to aid
the maintenance of robust lagging strand priming when Pol
-primase activity is reduced in vivo (112,113). The human
Ctf4-orthologue, AND-1, interacts with Pol -primase via
its C-terminal HMG box and displays DNA-binding ac-
tivity, potentially providing a mechanism by which Pol -
primase is directed to the lagging strand (114).
Discovery of a new class of eukaryotic primase
In the past, DNA primase enzymes were thought to pos-
sess one specific function: synthesising short RNA primers
during the initiation of DNA replication. However, more re-
cently, this has been shown to be somewhat of a functional
mis-annotation and nowhere is this more evident than in
members of the archaeo-eukaryotic primase (AEP) super-
family (reviewed in (103)). Enzymes belonging to this super-
family can be found throughout all domains of life, where
they have evolved specialist roles in replication, repair and
DNA damage tolerance.
Perhaps the best-known family member is Pri1 (PriS)
which, in complex with the large subunit (Pri2/PriL), syn-
thesises RNA primers during canonical origin firing and
lagging strand synthesis (13). In archaea, Pri1 can extend
primers with dNTPs in a manner similar to Pol , which
is lacking from these organisms (115). Archaeal Pri1 can
also conduct TLS over various helix-distorting lesions to
facilitate DNA damage tolerance (116). Pri1 is not the
only AEP discovered in archaea; for example, the archaeal
cryptic plasmid pRN1 encodes an enzyme, ORF904, which
contains a helicase/translocase domain in addition to the
AEP domain that renders the protein proficient in both
primase and polymerase activities (117). In fact, ORF904
can synthesise many kilobases of DNA when conducting
bulk replication of pRN1 plasmids. In addition, many bac-
terial species possess various AEP orthologues. For exam-
ple, RepB’ and Rep are AEPs found on RSF1010 and ColE2
plasmids, respectively, that more conventionally generate
short primers to initiate plasmid replication (118,119). Per-
haps even more intriguing is the discovery of AEP pro-
teins that are co-operonic with bacterial non-homologous
end joining (NHEJ) protein Ku (120,121). Here, the AEP
protein forms part of a larger DNA break repair com-
plex known as Ligase D (LigD), which further associates
with Ku (Ku-LigD complex) to facilitate prokaryotic NHEJ
(122). In mycobacteria, Prim-PolC is co-operonic with Lig-
ase C and plays a role in excision repair (123), binding to
the short gaps produced as part of this excision process and
conducting gap-repair synthesis (124). The AEP family has
recently been renamed as Primase-Polymerases (Prim-Pols)
to better reflect the more diverse origins and functions of
this replicase superfamily (103).
In 2005, a bioinformatic study identified a variety of
novel Prim-Pols, including a second Prim-Pol gene in the
human genome called CCDC111 (125). This gene product
was subsequently isolated and characterised (126–128). The
protein was shown to be a DNA-dependent DNA poly-
merase that also possesses TLS-like activities on lesion-
containing templates, such as 8-oxo-G and 6–4 pyrimidine
dimers. In addition, the enzyme showed robust primase ac-
tivity on DNA templates. However, in contrast to replica-
tive primases, it utilises dNTPs much more efficiently than
rNTPs (129). To reflect both of these capabilities, CCDC111
was renamed Primase-Polymerase (PrimPol). Human Prim-
Pol is a monomeric enzyme (130), differing from replica-
tive primase enzymes, which form heterodimers, such as
the eukaryotic primase complex Pri1/Pri2 (131). PrimPol
contains a characteristic N-terminal AEP domain contain-
ing three conserved motifs (I, II and III) that are essential
for all catalytic activities. Motif I contains residues (DxE)
that create a binding site for divalent metals (125) and mu-
tating these residues ablates catalytic activity (126–128). A
UL52-like zinc finger (ZnF) domain is located downstream
of the catalytic domain. This domain contains a conserved
sequence (Cys-His-Cys-Cys) that allows the coordination of
a metal ion to form a zinc finger. The ZnF domain binds
to ssDNA and appears to play a role in PrimPol’s priming
mechanism, as mutating/deleting it abolishes primase, but
not polymerase, activity (130,132,133). The C-terminal do-
main (CTD) of PrimPol binds to the single-strand binding
protein, replication protein A (RPA70) (128,134) and Prim-
Pol foci formation is dependent on this interaction (135).
A recent study elucidated the molecular basis of this in-
teraction and identified two RPA binding motifs, RBM-
A and RBM-B, contained within the CTD, which interact
with the basic cleft of RPA70N (135). PrimPol also binds
to PolDIP2 (PDIP38) and this enhances its polymerase, but
not its priming, activities (136), although the specific cellu-
lar role of this complex remains to be established.
Establishing a role for PrimPol in vertebrate cells
Orthologues of PrimPol are found in most eukaryotic or-
ganisms, with a few notable exceptions, such as S. cere-
visiae, S. pombe, Caenorhabditis elegans and Drosophila
melanogaster. Our current understanding of the enzyme’s
in vivo functions comes predominantly from avian and hu-
man cell studies. PrimPol knockout avian cells (DT40) show
a pronounced sensitivity to UV-C damage, 4NQO (a UV
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mimetic), cisplatin, chain-terminating nucleotide analogues
(CTNAs) and MMS, but no greater sensitivity to agents
that induce double-strand breaks (126,137,138). These cells
also exhibited a distinct G2-M checkpoint response af-
ter UV damage (137). In contrast to Pol  knock out
cells, which also display UV-C sensitivity, no loss in post-
replicative repair of UV-C damage was observed when
PrimPol is depleted (130,137). Fork speeds and general fork
progression are decreased in PrimPol’s absence. This is espe-
cially prominent following UV damage, strongly suggesting
a role for PrimPol in the maintenance of fork progression
after DNA damage.
The importance of PrimPol in DNA damage tolerance
was further supported by studies of human PrimPol−/−
MRC-5 cells (139), which also showed decreased fork
speeds and increased fork stalling after damage, although
the damage sensitivity observed in avian cells was not ob-
served in the human knock out (or knock down) cells (126).
This discrepancy is likely due to the significantly shorter
doubling time of DT40 cells compared to human cells – 11
hours compared to 24 hours (140,141). Human PrimPol−/−
cells also exhibit a variety of phenotypes that highlight the
important roles this protein plays in maintaining DNA sta-
bility in both the nucleus and mitochondria. These include
increased micronuclei, sister chromatin exchanges and mu-
tation frequency (139).
While PrimPol evidently plays an important role in tol-
erating lesions, it is important to acknowledge that Prim-
Pol is also involved in maintaining replication during stress
(Figure 3A). Hydroxyurea (HU) slows and stalls replica-
tion by inhibiting ribonucleotide reductase, thus depleting
the cellular dNTP pool. Upon treatment with HU, human
cells exhibit both an increase in chromatin-bound Prim-
Pol and a relocalisation of PrimPol into subnuclear foci
(126,132). In PrimPol depleted cells, HU treatment causes
a decrease in fork progression, as measured by DNA fi-
bre analysis, which can be rescued by expressing wild-type
PrimPol, but not a primase-deficient version of the enzyme
(132). A recent CRISPR screen implicated PrimPol in the
response to resveratrol and its chemical analogue pteros-
tilbene (142). Like HU treatment, Resveratrol also induces
comparable dNTP depletion and fork speed decrease, high-
lighting the drug’s ability to cause replication stress. Over-
all, these studies suggest that PrimPol also performs a more
general ‘house-keeping’ role in maintaining unperturbed
fork progression in response to replication slowing and en-
dogenous fork stalling.
PrimPol reprimes downstream of lesions and stalling struc-
tures in vivo
Recent studies have begun to establish the roles that Prim-
Pol plays in vivo, which ultimately underlie the phenotypes
observed in its absence. Early studies noted that PrimPol
was required to maintain replication fork speed following
UV exposure and that this effect was dependent on its pri-
mase activity (Figure 3A) (126,130,132). Interestingly, pre-
vious studies had already suggested that UV-stalled forks
were restarted via repriming in human cells (87,143). There
is also evidence that PrimPol reprimes downstream of AP-
sites, and this activity has been suggested to allow some
cells to tolerate the mutagenic lesions produced by the
APOBEC/AID family of cytosine deaminases (144). Us-
ing avian cells, it was shown that PrimPol also mediates
tolerance to chain-terminating nucleoside analogues (CT-
NAs) (Figure 3A), which stall DNA replication (138). Cells
deficient in PrimPol experienced a significant decrease in
survival after treatment with CTNAs, which can be com-
plemented by the introduction of WT PrimPol, but not
a primase-deficient mutant. The mechanism underpinning
the tolerance was supported by in vitro studies demonstrat-
ing that PrimPol could synthesise a de novo primer ∼14 nu-
cleotides downstream of a CTNA present at the 3′ end of a
primer strand (138). A depiction of replication restart me-
diated by PrimPol following fork stalling is shown in Figure
3B and Figure 3C.
PrimPol has additionally been implicated in the tolerance
of DNA structures, such as G4-quadruplexes (Figure 3A)
(145). Using histone recycling as a measurement of repli-
some uncoupling in DT40 cells, Schiavone et al. found local
epigenetic instability in the absence of PrimPol around the
BU-1A locus when a G4 structure was present on the lead-
ing strand. While PrimPol does not directly replicate G4′s,
it was shown to reprime downstream of these structures, al-
lowing rapid resumption of replication and preventing repli-
some uncoupling. The system was later adapted to study
the potential role of PrimPol in R-loop bypass by replacing
the G4 quadruplex sequence with R-loop forming purine-
rich repeats of (GAA)n (146). In a WT background, short
tracts of repeats (n = 10) did not affect the epigenetic sta-
bility, indicating that the replisome can move through the
region unhindered. Strikingly, in PrimPol knock-out cells,
the same short tracts caused a significant increase in the lo-
cal epigenetic instability, indicative of fork stalling, which
could only be rescued by expression of primase-proficient
PrimPol.
The abilities of PrimPol demonstrated by the studies de-
scribed above highlight its role in the tolerance of a myriad
of fork-stalling lesions and structures (Figure 3A). Interest-
ingly, while multiple studies of PrimPol have demonstrated
TLS capabilities in vitro, evidence supporting its use in vivo
remains to be established. Hence, the current consensus is
that PrimPol’s primary role in vivo is to reprime DNA syn-
thesis; while a role in TLS cannot be ruled out, it can be as-
sumed that the majority of phenotypes observed in the ab-
sence of PrimPol are caused by the cell’s inability to reprime
stalled DNA replication, particularly on the leading strand
(126,127,130,132). Previously, there was no known mech-
anism to facilitate repriming on the leading strand in ver-
tebrate cells; however, considering all of the evidence now
available, it is apparent that PrimPol-mediated repriming
provides cells with a highly flexible mechanism for restart-
ing DNA synthesis and bypassing obstacles on the leading
strand thus preventing replication stress. It should be noted
that PrimPol may also prime on the lagging strand, how-
ever, this would seem redundant given the activity of Pol -
primase. The discovery and characterisation of a PrimPol-
dependent repriming pathway also provides additional ev-
idence to support a model for discontinuous synthesis on
both strands during DNA synthesis.
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Figure 3. PrimPol-dependent repriming of stalled replication intermediates. (A) PrimPol-mediated repriming can assist in resolving fork stalling after
many different kinds of lesions, including CTNAs, bulky lesions such as those generated by UV light, G-4 quadruplexes, R-loops, and intra/interstrand
crosslinks. PrimPol can also be utilised when low dNTPs pools cause fork stalling. Additionally, the absence or loss of an alternative DDT pathway, such
as fork reversal, can lead to the deployment of a PrimPol-dependent pathway. (B) Replication fork uncoupling occurs when lesions, or other sources of
replication stress, transiently stall the replicative polymerase without impeding the rest of the replisome. This uncoupling generates stretches of ssDNA
onto which RPA can bind. (C) PrimPol (pink oval) can be recruited to these tracts of RPA bound ssDNA to facilitate the restart of the uncoupled fork
by repriming. From here, the replicative polymerase will take over to complete synthesis. The repriming depicted here occurs on the leading strand, with
lagging strand machinery omitted for clarity.
Repriming DNA synthesis represents a canonical damage tol-
erance pathway
While evidence for the existence of DNA damage tolerance
mechanisms that involve repriming downstream of repli-
case stalling obstacles has been invoked for over half a cen-
tury, it is still rarely regarded as an actual canonical DDT
pathway. This might be because the replicative primases
of prokaryotes, and probably some other organisms too,
have the intrinsic ability to reprime DNA synthesis and are,
therefore, not considered to represent a distinct DDT path-
way. Furthermore, the roles of other Prim-Pol enzymes in
various other genome stability pathways have only recently
been appreciated (103). In addition, the relatively mild phe-
notypes displayed by human cells depleted of PrimPol do
not, at an initial glance, mark this out as a major pathway
of DDT. While PrimPol deficient human cells do exhibit
a change in cell cycle profile and modest slowing of repli-
cation forks, they do not display overt signs of distress or
growth impediments (139). Interestingly, the effects of los-
ing PrimPol seems to vary between organisms. For exam-
ple, avian PrimPol−/− cells exhibit more pronounced phe-
notypes, specifically a sensitivity to fork stalling lesions, in
addition to profound G2 stalling after UV damage that is
only partially resolved by the application of Chk1 or p38
inhibitors (126,137). PrimPol−/− mice remain viable with-
out displaying any overt phenotypes. Mouse embryonic fi-
broblasts (MEFs) lacking PrimPol display increased chro-
matid breaks, suggesting the generation of lesions during S
phase (126,127). Depletion of a PrimPol orthologue, PPL2,
in trypanosomes results in a lethal mitotic catastrophe-like
phenotype, likely due to replication defects, highlighting an
essential role for PrimPol in these protists (147).
An ever-increasing number of recent studies are report-
ing functional overlaps between repriming and other DDT
pathways, suggesting that the impact of repriming is of-
ten underestimated, as its absence can be compensated for
by other pathways. The first such overlap to be described
was observed while studying PrimPol depletion in xero-
derma pigmentosum variant (XP-V) cells (126,139). XP-V
cells contain mutations in the POLH gene, which encodes
the TLS polymerase Eta (Pol ) (91). Pol  provides toler-
ance to UV-induced damage by conducting error-free by-
pass of CPD lesions. Due to PrimPol’s proficiency in con-
ducting TLS-like bypass of UV-induced lesions (6–4 PPs)
and extending from CPDs in vitro, it was hypothesised that
the two enzymes could work in complementary pathways
(126). To test this, PrimPol was depleted in both WT and
XP-V cells before applying a dose of UV radiation. Both
cell types exhibited increased RPA foci and a concurrent in-
crease in phosphorylation of the intra-S checkpoint kinase
Chk1 in response to UV-induced damage. Interestingly, in
cells lacking both Pol  and PrimPol, levels of Chk1 phos-
phorylation remained elevated for significantly longer than
cells deficient in only one enzyme, suggesting a complete de-
ficiency in UV damage bypass when both enzymes are re-
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moved. While both PrimPol-depleted fibroblasts and XP-V
exhibited either absent or mild UV-C sensitivity, in the ab-
sence of caffeine, PrimPol-depleted XP-V cells become syn-
ergistically sensitive to UV irradiation, establishing a non-
epistatic relationship between these distinct DDT pathways.
PrimPol’s role in DNA damage tolerance was also shown
to be independent of Pol  in avian cells, where its absence
exacerbated the phenotypes of Pol /Pol  knockout cells
(138). Notably, complementing PrimPol−/− cells with a pri-
mase defective, but polymerase/TLS active, PrimPol did not
rescue their damage sensitivity, further supporting the no-
tion that PrimPol’s primary role in vivo is to reprime DNA
synthesis (130,138). These studies demonstrate how the ex-
istence of complementary damage tolerance pathways can
mask the effects of losing one mechanism alone.
Another proposed DDT mechanism involves fork rever-
sal following a major replisome stalling event. The breast
cancer-associated (BRCA) proteins (BRCA-1 and BRCA-
2) have been suggested to protect reversed forks from nucle-
olytic degradation and therefore promote bypass of DNA
lesions by homologous recombination (148,149). Muta-
tions in these genes are the leading cause of familial breast
and ovarian cancers (150). As BRCA proteins protect repli-
cation forks undergoing reversal from degradation, BRCA
null cell lines may be susceptible to increased genomic in-
stability brought on by extensive fork degradation (55).
It was reported that the fork degradation phenotype typ-
ically displayed by BRCA1 deficient cells after a single
dose of cisplatin is absent after treatment with multiple
doses, with cells exhibiting increased replication fork speeds
(151). Overexpressing WT PrimPol, but not catalytically-
or primase-inactive mutants, protected against the degra-
dation phenotype observed in BRCA deficient cells. These
results suggest that cells may upregulate their PrimPol-
dependent repriming pathway in order to compensate for
the loss of fork reversal as an alternative mechanism of
cisplatin tolerance. Supporting this, following multiple cis-
platin doses, PrimPol mRNA levels were significantly ele-
vated and chromatin-bound PrimPol increased in BRCA-1
deficient cells, but not in cells complemented with BRCA-
1. The increase in mRNA was found to be regulated by
ATR. Another recent study reported that the USP36 pro-
tease also possibly plays a role in regulating PrimPol protein
levels (152), and the ATPase WRNIP1 has been suggested
to target PrimPol protein for degradation (153). This sug-
gests that multiple mechanisms exist that regulate PrimPol
deployment in human cells. This is probably not surpris-
ing as a failure to suppress ssDNA gaps has been suggested
to be a major hallmark of BRCA-deficient cancers and a
cause of their sensitivity to chemotherapeutic agents (154).
Uncontrolled repriming may lead to a similar increase in
ssDNA gaps, decreasing cell fitness unless cells can com-
pensate, e.g. by increasing TLS activity as observed in some
cancer cells (155).
Another study by Bai et al. (156) investigating cells defi-
cient in the fork remodeller HLTF reached similar conclu-
sions to those of Quinet et al. (151). HLTF is an SWI/SNF
family chromatin remodelling enzyme that promotes fork
reversal and, in its absence, PrimPol is required to maintain
efficient fork progression, leading to the accumulation of ss-
DNA gaps (157,158). PrimPol’s action at the fork appears
to confer replication stress resistance and allow S phase to
continue without slowing of DNA synthesis. However, if
HLTF is present and allowed to bind to the replication fork
but contains an inactive HIRAN domain (the domain that
binds the 3′-hydroxyl group of nascent DNA), PrimPol is
outcompeted at the fork and does not act, and the role of S
phase progression is undertaken by Rev1. Similar work has
shown that in the absence of CARM1, a protein implicated
in the stabilisation of reversed forks, PrimPol and TLS are
both employed in restarting replication forks (159). The bal-
ance between these complementary DTT pathways there-
fore has the potential to mask the key roles that repriming
undertakes in vivo.
Repriming is not the end of the story...
In eukaryotes, PrimPol’s repriming activities allow repli-
cation to continue past lesions, structures and other im-
pediments. However, once synthesised, the primer is likely
to be some distance away from the CMG complex due to
helicase uncoupling that accompanies leading-stand fork
stalling (160). In order to restore efficient canonical repli-
cation, synthesis must be recoupled to the CMG. In the
case of TLS, Pol  conducts leading-strand synthesis follow-
ing lesion bypass, which fits well with the previous reports
of Pol  replicating both strands after replication restart
(9,10). PrimPol interacts with, and is stimulated by, Poly-
merase -interacting protein 2 (PolDIP2), which may facili-
tate a handoff from PrimPol to Pol , once primer synthesis
is complete (136,161,162). Pol  could then synthesise until
replication can be recoupled to CMG-Pol ε, as is the case
following TLS (9,163).
One of the major distinctions between the two human
primases is that Pri1 produces an RNA primer, while Prim-
Pol synthesises a predominantly DNA polymer. This pref-
erence to reprime using dNTPs may facilitate a more ef-
ficient restarting of DNA synthesis as high fidelity repli-
cases preferentially copy B-form DNA templates, whereas
priming with an RNA polymer produces an RNA–DNA
hybrid that is a much poorer A-form substrate. In addi-
tion, it also eliminates the requirement for Pol -dependent
synthesis prior to primer handover to Pol /Pol ε. DNA
primers may also be preferred to avoid introducing breaks
on the leading strand. Following replication, RNA primers
are subsequently excised (e.g. Fen1/Pol I) and then replaced
with DNA to maintain genome integrity. However, during
PrimPol-dependent repriming, it is likely that dNTPs are
preferentially incorporated to prevent the processing and re-
moval of the newly synthesised primers as this could result
in undesirable strand breaks that are particularly danger-
ous on the leading strand. Notably, PrimPol incorporates
a single initiating 5′ ribonucleotide during primer synthesis
but this is likely removed by the RNase HII pathway in a
post-replicative fashion (127,164).
Reinitiating DNA synthesis from a downstream primer
generates a single-stranded gap in the nascent chain oppo-
site the unresolved stalling lesion or structure. To complete
replication, gaps must be filled in a manner that is indepen-
dent of the global genome replication process. Interestingly,
this event was not found to occur in any known DNA re-
pair centres; instead, the majority of ssDNA accumulates in
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post-replicative repair territories (PORTs) (165). Here, TLS
or template-switching pathways facilitate the removal of the
ssDNA gaps. TLS does not solely occur directly at an active
fork - following the monoubiquitination of PCNA, TLS en-
zymes can synthesise over bypassed UV lesions in a post-
replicative manner to fill gaps that result from repriming
(166). A recent study has also implicated homologous re-
combination in the gap-filling process at PrimPol-mediated
ssDNA gaps in human cells (167). As part of this process,
MRE11 and EXO1 facilitate 3′ to 5′ resection of DNA
gaps to expose sufficient ssDNA for the loading of the
HR protein, Rad51. Subsequent template switching allows
the replication of the gapped region by using the unim-
paired sister chromatid as a template. Presumably, persis-
tent fork-stalling DNA structures must be resolved using
the canonical mechanisms before opposing gaps can be
filled.
Coping without a bespoke repriming pathway
Since repriming represents a major canonical DDT path-
way in most cells, how do organisms without spe-
cialised repriming mechanisms (e.g., budding/fission yeast,
drosophila, C. elegans) deal with leading strand stalling
events? As discussed, in prokaryotes this appears to be re-
solved by simply repurposing the replicative primases to
also reinitiate replication. However, evidence to suggest that
a similar process occurs in eukaryotic organisms is lack-
ing. It is very likely that cells without a bespoke reprim-
ing pathway may simply rely on alternative DDT pathways
and mechanisms to ultimately maintain genome stability
without the requirement to conduct leading strand reprim-
ing. One such viable alternative pathway involves using TLS
and, in fact, the budding yeast replisome has been shown
to efficiently utilise Pol  to bypass leading strand lesions
‘on the fly’ (9). Additionally, recent findings indicate that
the yeast replisome is itself inherently tolerant of oxidative
damage (168). Upon encountering a leading strand thymine
glycol or 8-oxo-G, Pol ε is switched for Pol , which con-
ducts rapid, error-free synthesis over the lesion. There is also
some evidence to potentially support a similar role for Pol 
in higher eukaryotes, although this mechanism remains to
be established (169–171).
In addition, other functionally overlapping DDT path-
ways could also offer sufficient protection against the dele-
terious effects of leading strand lesions. For example, yeast
cells display an abundance of recombination intermediates
associated with fork reversal and temple-switching, in fit-
ting with the preferential usage of recombination pathways
by these organisms (reviewed in (172)). It is therefore likely
that HR and other DDT pathways (e.g TLS, dormant origin
firing) readily compensate for the lack of repriming mech-
anisms and these alternative mechanisms may even provide
more efficient replication restart solutions for some organ-
isms.
CONCLUDING REMARKS
Since the seminal studies of Rupp and Howard-Flanders,
the precise nature of leading strand synthesis has been de-
bated (82). The initial evidence pointed to a mechanism
whereby all DNA was synthesised in small pieces, regardless
of which strand, leading or lagging, the nascent chain orig-
inated. A plethora of conflicting publications made it diffi-
cult to draw concrete conclusions and it seems the field grav-
itated towards the mechanistically simpler model of con-
tinuous leading strand synthesis from origin to termina-
tion. The discovery of TLS enzymes made the continuous
argument even more appealing, as these enzymes offered
an explanation as to how lesions could be bypassed with-
out breaking the continuous nascent chain (89–91). How-
ever, the idea of repriming was not forgotten and later stud-
ies provided some compelling evidence of leading strand
repriming occurring in bacteria and yeast (88,93,94). The
discovery and subsequent characterisation of a second pri-
mase enzyme in vertebrate cells (PrimPol) has now estab-
lished that a similar process also occurs in most eukary-
otic cells and represents a key additional DDT pathway for
maintaining efficient fork progression (161). With more re-
search being conducted into leading strand repriming, it is
becoming apparent that it offers a flexible replication restart
pathway that is an ideal solution for bypassing a wide vari-
ety of fork stalling impediments, that can subsequently be
resolved in a post-replicative manner. This is most appar-
ent in studies that demonstrate functional redundancies be-
tween repriming and a variety of specific pathways for tol-
erating damage (126,139). Thus, after examining all of the
available evidence, it is clear that repriming on the leading
strand should now be considered a canonical DDT pathway
in a wide range of organisms, from bacteria to human cells.
In fact, repriming may even represent the original DDT
pathway as it is also required to maintain efficient DNA du-
plication during unperturbed replication.
Although the significance of repriming mechanisms in
vertebrate cells is becoming more evident, much remains
to be discovered about this process. Since aberrant prim-
ing on ssDNA is clearly undesirable, there are likely many
undiscovered regulatory mechanisms to ensure that the us-
age of repriming pathways is strictly restricted to when and
where they are required. Additionally, taking into account
the diverse range of functions displayed by other Prim-Pol
superfamily members (103), it seems plausible that Prim-
Pol may undertake additional roles in DNA replication and
repair, e.g. TLS or gap repair synthesis. Since PrimPol is
involved in an important mechanism that maintains repli-
cation restart in human cells, defects in this pathway are
likely to have a role in genetic diseases. A specific Prim-
Pol mutation has already been identified as a susceptibility
gene for high myopia (173), although its role in the devel-
opment of this condition has not been established. Addi-
tionally, PrimPol alterations have been observed in cancers,
with overexpression of PrimPol reported in glioblastoma
and a point mutation identified in lung cancer (174,175).
Interestingly, DNA primase (PRIM1) mutations have re-
cently been linked to the development of Microcephalic Pri-
mordial Dwarfism (MPD) (176), further demonstrating the
association of primase mutations with disease states and
highlighting the need for further research into the exact
mechanisms that underpin this canonical DNA replication-
associated restart pathway.
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Hurwitz,J., van Oijen,A., Schärer,OD. and Walter,J.C. (2011)
Selective bypass of a lagging strand roadblock by the eukaryotic
replicative DNA helicase. Cell, 146, 931–941.
7. Kuchta,R.D. and Stengel,G. (2010) Mechanism and evolution of
DNA primases. Biochim. Biophys. Acta (BBA)-Proteins Proteomics,
1804, 1180–1189.
8. Clausen,A.R., Lujan,S.A., Burkholder,A.B., Orebaugh,C.D.,
Williams,J.S., Clausen,M.F., Malc,E.P., Mieczkowski,P.A.,
Fargo,D.C. and Smith,D.J. (2015) Tracking replication enzymology
in vivo by genome-wide mapping of ribonucleotide incorporation.
Nat. Struct. Mol. Biol., 22, 185–191.
9. Guilliam,T.A. and Yeeles,J.T. (2020) Reconstitution of translesion
synthesis reveals a mechanism of eukaryotic DNA replication
restart. Nat. Struct. Mol. Biol., 27, 450–460.
10. Miyabe,I., Mizuno,K.I., Keszthelyi,A., Daigaku,Y., Skouteri,M.,
Mohebi,S., Kunkel,T.A., Murray,J.M. and Carr,A.M. (2015)
Polymerase  replicates both strands after homologous
recombination–dependent fork restart. Nat. Struct. Mol. Biol., 22,
932–938
11. Lujan,S.A., Williams,J.S. and Kunkel,T.A. (2016) DNA polymerases
divide the labor of genome replication. Trends Cell Biol., 26,
640–654.
12. Miyabe,I., Kunkel,T.A. and Carr,A.M. (2011) The major roles of
DNA polymerases epsilon and delta at the eukaryotic replication
fork are evolutionarily conserved. PLos Genet., 7, e1002407.
13. Pellegrini,L. (2012) The Pol -primase complex. Eukaryotic
Replisome, 62, 157–169.
14. Baker,T.A. and Wickner,S.H. (1992) Genetics and enzymology of
DNA replication in Escherichia coli. Annu. Rev. Genet., 26, 447–477.
15. Dua,R., Levy,D.L., Li,C.M., Snow,P.M. and Campbell,J.L. (2002)
In vivo reconstitution of Saccharomyces cerevisiae DNA polymerase
ε in insect cells purification and characterisation J. Biol. Chem., 277,
7889–7896.
16. Chilkova,O., Stenlund,P., Isoz,I., Stith,C.M., Grabowski,P.,
Lundström,E.-B., Burgers,P.M. and Johansson,E. (2007) The
eukaryotic leading and lagging strand DNA polymerases are loaded
onto primer-ends via separate mechanisms but have comparable
processivity in the presence of PCNA. Nucleic Acids Res., 35,
6588–6597.
17. Dewar,J.M. and Walter,J.C. (2017) Mechanisms of DNA replication
termination. Nat. Rev. Mol. Cell Biol., 18, 507–516.
18. Franz,A., Orth,M., Pirson,P.A., Sonneville,R., Blow,J.J.,
Gartner,A., Stemmann,O. and Hoppe,T. (2011) CDC-48/p97
coordinates CDT-1 degradation with GINS chromatin dissociation
to ensure faithful DNA replication. Mol. Cell, 44, 85–96.
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